5 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio

In this article, we discuss the 5 growth stocks under $20 in billionaire Ken Fisher’s portfolio. If you want to read our detailed analysis of these stocks, go directly to the 10 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio.

5. iQIYI, Inc. (NASDAQ:IQ)

Number of Hedge Fund Holders: 23 

Price as of December 5, 2021: $4.71 per share      

iQIYI, Inc. (NASDAQ:IQ) provides online entertainment services.  Regulatory filings show that Fisher Asset Management owned 67,088 shares in the company at the end of the third quarter of 2021 worth over $539,000. 

iQIYI, Inc. (NASDAQ:IQ) recently posted earnings for the third quarter, reporting a revenue of more than $1.2 billion, smashing analyst predictions by $10 million. Citi analyst Alicia Yap has a Neutral rating on the stock with a price target of $8.8. 

Among the hedge funds being tracked by Insider Monkey, China-based investment firm Hillhouse Capital Management is a leading shareholder in iQIYI, Inc. (NASDAQ:IQ) with 38 million shares worth more than $310 million.

4. Invitae Corporation (NYSE:NVTA)

Number of Hedge Fund Holders: 24  

Price as of December 5, 2021: $14.99 per share  

Invitae Corporation (NYSE:NVTA) operates as a medical genetics company. According to the latest data, Fisher Asset Management owned 833,946 shares in the firm at the end of September 2021 worth $23 million, representing 0.01% of the portfolio of the fund. 

On October 14, investment advisory Cowen maintained an Outperform rating on Invitae Corporation (NYSE:NVTA) stock with a price target of $40. Dan Brennan, an analyst at the advisory, issued the ratings update. 

At the end of the third quarter of 2021, 24 hedge funds in the database of Insider Monkey held stakes worth $1.8 billion in Invitae Corporation (NYSE:NVTA), down from 31 in the preceding quarter worth $2.1 billion.   

3. ImmunoGen, Inc. (NASDAQ:IMGN)

Number of Hedge Fund Holders: 26

Price as of December 5, 2021: $6.62 per share    

ImmunoGen, Inc. (NASDAQ:IMGN) is a biotech firm that develops therapies for cancer. Securities filings show that Fisher Asset Management owned 84,798 shares in the company at the end of the third quarter of 2021 worth $481,000. 

On December 2, ImmunoGen, Inc. (NASDAQ:IMGN) announced that it had managed to raise over $257 million in capital through an equity offering of around 11 million common shares at $6.60 per share. The company will use the proceeds to fund operations and for business development.

At the end of the third quarter of 2021, 26 hedge funds in the database of Insider Monkey held stakes worth $362 million in ImmunoGen, Inc. (NASDAQ:IMGN), the same as in the preceding quarter worth $421 million. 

2. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Number of Hedge Fund Holders: 27

Price as of December 5, 2021: $10.98 per share  

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is a Boston-based healthcare company. Fisher Asset Management owned 85,918 shares in the firm at the end of September 2021 worth $1.1 million. 

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) posted earnings for the third quarter in early November, reporting earnings per share of $0.33, beating market estimates by $0.01. The revenue over the period was $103 million, up 0.3% year-on-year. 

At the end of the third quarter of 2021, 27 hedge funds in the database of Insider Monkey held stakes worth $442 million in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), down from 28 the preceding quarter worth $498 million.

1. Hewlett Packard Enterprise Company (NYSE:HPE)

Number of Hedge Fund Holders: 33   

Price as of December 5, 2021: $15.17 per share  

Hewlett Packard Enterprise Company (NYSE:HPE) provides technology, hardware, and storage solutions. At the end of the third quarter of 2021, Fisher Asset Management owned 10,839 shares in the company worth $154,000. 

Raymond James analyst Simon Leopold recently raised the price target on Hewlett Packard Enterprise Company (NYSE:HPE) stock to $21 from $20 and kept an Outperform rating, underlining the order growth of the firm as an encouraging sign for investors. 

At the end of the third quarter of 2021, 33 hedge funds in the database of Insider Monkey held stakes worth $1 billion in Hewlett Packard Enterprise Company (NYSE:HPE), down from 34 in the previous quarter worth $1.01 billion.

You can also take a peek at 10 Best Medical Stocks Under $10 and 10 Best Cash App Stocks to Invest In.